Palo Alto, CA, United States
Disclosure information not submitted.
SUN-064 - Sustained Progression-Free Survival after 2 Years of Immune Checkpoint Inhibitor Therapy in A Patient with Metastatic Pituitary Carcinoma
Sunday, June 14, 20269:00 AM - 4:00 PM CT
SUN-531 - Implementing Continuous Glucose Monitors in Primary Care - A Teaching Module for Internal Medicine Residents
.jpg)
.jpg)
